Description
小懂健康是一款非常好用的患者随访管理工具，全国众多的心理医生都在使用。为什么要使用小懂健康？精神心理疾病的核心问题是居高不下的“误诊率”和“复发率”。大数据和人工智能技术的日臻成熟，为精神心理疾病的辅助诊疗带来的新机遇。公司产品利用大数据、人工智能技术建立诊疗模型，有效提高了精神心理疾病的诊疗水平。传统问诊模式下，精神障碍识别率仅在50%左右，治疗后三年复发率超过80%。我们创新的运用“技术+数据+服务”的模式，为医生赋能，使诊断正确率 提升到90%以上，三年复发率降低到30%左右。
Screenshots
小懂健康 FAQ
-
Is 小懂健康 free?
Yes, 小懂健康 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 小懂健康 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 小懂健康 cost?
小懂健康 is free.
-
What is 小懂健康 revenue?
To get estimated revenue of 小懂健康 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Poland yet.
Ratings History
小懂健康 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
Keywords
小懂健康 Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
京东医生
|
Unlock
|
Unlock
|
0
|
|
1 week ago | |
昭阳医生医生版
精神科医生/心理咨询师服务平台
|
Unlock
|
Unlock
|
0
|
|
3 weeks ago | |
昭阳医生患者版
心理科在线问诊拿药、心理咨询一站式服务
|
Unlock
|
Unlock
|
0
|
|
3 weeks ago | |
智云医生
医护人员的实用助手
|
Unlock
|
Unlock
|
0
|
|
2 months ago | |
微脉医生版-为医生打造的线上诊间
医患沟通医疗资讯专病服务
|
Unlock
|
Unlock
|
0
|
|
4 weeks ago | |
施强健康
|
Unlock
|
Unlock
|
0
|
|
1 week ago | |
病历夹
|
Unlock
|
Unlock
|
0
|
|
2 weeks ago | |
好心情医生版
|
Unlock
|
Unlock
|
0
|
|
3 weeks ago | |
怡宁健康v2
怡宁健康医生版
|
Unlock
|
Unlock
|
0
|
|
4 months ago | |
家有好医-医生的掌上工作室
让行医更简单，就医更便捷
|
Unlock
|
Unlock
|
0
|
|
3 weeks ago |
小懂健康 Installs
Last 30 days
小懂健康 Revenue
Last 30 days小懂健康 Revenue and Downloads
Gain valuable insights into 小懂健康 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Languages
- Chinese
- Recent release
- 5.7.24 (1 month ago )
- Released on
- Apr 16, 2019 (5 years ago )
- Also available in
- China , Poland , Italy , Japan , South Korea , Kuwait , Kazakhstan , Lebanon , Mexico , Malaysia , Nigeria , Netherlands , Norway , New Zealand , Peru , Philippines , Pakistan , India , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Dominican Republic , Argentina , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Canada , Switzerland , Chile , Colombia , Czechia , Germany , Denmark , United Arab Emirates , Algeria , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Ireland , Israel
- Last Updated
- 3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.